Background: Differentiating glioblastoma (GBM), brain metastases, and primary central nervous system lymphoma (PCNSL) in clinical practice is difficult. This study aimed to evaluate the diagnostic value of routine blood biomarkers in patients with GBM, brain metastases, and PCNSL and find a preoperative differential diagnostic tool for these tumors. Methods:The perioperative medical records of 70 GBM, 41 PCNSL, and 81 brain metastases patients and their preoperative blood test results were compared and analyzed, and a diagnostic model to differentiate among them established.Results: Patient age, plateletcrit, international normalized ratio (INR), and thrombin time (TT) were independently associated with differential diagnosis by multinomial logistic regression. Compared with GBM patients, brain metastases patients were significantly older (OR =1.055, 95% CI: 1.016-1.094, P=0.005) and had lower plateletcrit levels (OR =0.008, 95% CI: 0.004-0.017, P=0.027). In addition, patients with GBM had lower INR and higher TT than patients with the other two tumor types. A diagnostic model including these parameters, had an accuracy of 88.2% and 76.1% for brain metastases and GBM, respectively.Conclusions: Preoperative plateletcrit, INR, and TT may be used as inexpensive blood diagnostic biomarkers for differentiating brain metastases from other intracranial malignant tumors.
BackgroundIn clinal practice, differentiating glioblastoma (GBM), brain metastases (BM) and primary central nervous system lymphoma (PCNSL) preoperatively is difficult and directly affects the therapy of patients. This study was to evaluate the diagnostic value of routine blood biomarkers in patients with GBM, BM and PCNSL, and find a preoperative differential diagnostic tool for the three brain tumors.MethodsThe perioperative medical records of 70 GBMs, 41 PCNSLs and 81 BMs and their preoperative blood test results were compared and analyzed. A diagnosis model was founded for differentiating GBM, BM and PCNSL.ResultsPatient age, plateletcrit (PCT), international normalized ratio (INR) and thrombin time (TT) were found independently associated with differentiating diagnosis of the three brain tumors analyzed by multinomial logistic regression. Compared with GBM patients, BM patients tend to be elder (OR=1.055, 95% CI 1.016-1.094, p=0.005) and have lower PCT level (OR=0.008, 95% CI 0.004-0.017, p=0.027). Besides, GBM patients own lower INR and higher TT when compared with PCNSL patients and BM patients. We build an efficient diagnostic model with these parameters and diagnosis accuracies of this model were 88.2% and 76.1% in BM and GBM, respectively. ConclusionsThe preoperative PCT, INR and TT may be used as inexpensive blood diagnostic biomarkers for differentiating patients with brain metastases from other intracranial malignant tumors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.